PAV-220830FLY-315

samples-publishAS-BCG_PAV.xlsx

PAV-220830FLY-315

21319-190925

NHP-220830FLY-60

infusion premed. , pre-dosing vitals; HR 130, RR40, T 102.2. Interim vitals; HR 140, RR 36, T102.0 End of infusion vitals; HR 150, RR 42, T 101.8. No adverse reaction, anti-cd4 infusion

https://fairdomhub.org/sops/795

Treatment

Not specified

Flynn Lab

2019-09-25 00:00:00

JoAnne Flynn

Acetaminophen

Medication

Orally

80

milligram

Anti CD4

Antibody

Intravenously

275

milligram

Diphenhydramine

Medication

Intramuscularly

6

milligram

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

AB-220907FLY-2

Not specified

Not specified

help Creators and Submitter
Creators
Not specified
Submitter
Activity

Views: 10

Created: 3rd Feb 2025 at 21:09

Last updated: 4th Feb 2025 at 00:34

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
(v.1.16.1)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH